November 19th, 2013
An Insider’s Look at TACT
Gervasio Antonio Lamas, MD
TACT investigator Gervasio Lamas provides an inside look at how the TACT trial began, the controversial journey so far, and what he hopes it will accomplish.
November 19th, 2013
TACT Substudy Suggests Possible Strong Benefit for Chelation in Diabetics
Larry Husten, PHD
One year ago the results of the TACT trial were published in JAMA, sparking an enormous controversy over the propriety of publishing a trial suggesting that chelation therapy might be beneficial in people with cardiovascular disease. Chelation therapy has long been a staple of alternative medicine, but until the publication of TACT it had received […]
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?